Tempest Therapeutics, Inc. Available-for-sale Securities, Gross Unrealized Gains (Deprecated 2013-01-31)
Tempest Therapeutics, Inc. (TPST) had Available-for-sale Securities, Gross Unrealized Gains (Deprecated 2013-01-31) of $9.00 thousand as of 2013-09-30, per its 10-Q filed 2013-11-13.
Discontinued › Notes › Investments
us-gaap:AvailableforsaleSecuritiesGrossUnrealizedGain · last filed 2013-11-13
- 2013-09-30: Available-for-sale Securities, Gross Unrealized Gains (Deprecated 2013-01-31) $9.00K.
- 2013-06-30: Available-for-sale Securities, Gross Unrealized Gains (Deprecated 2013-01-31) $1.00K.
- 2013-03-31: Available-for-sale Securities, Gross Unrealized Gains (Deprecated 2013-01-31) $4.00K.
- 2012-12-31: Available-for-sale Securities, Gross Unrealized Gains (Deprecated 2013-01-31) $5.00K.
| Period end | Available-for-sale Securities, Gross Unrealized Gains (Deprecated 2013-01-31) |
|---|---|
| 2013-09-30 | $9.00K 10-Q · filed 2013-11-13 |
| 2013-06-30 | $1.00K 10-Q · filed 2013-08-13 |
| 2013-03-31 | $4.00K 10-Q · filed 2013-05-15 |
| 2012-12-31 | $5.00K 10-Q · filed 2013-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B |